期刊文献+

良恶性胸腔积液细胞端粒酶活性的研究 被引量:1

Detection of telomerase activity in bengin and malignant pleural effusion cells
下载PDF
导出
摘要 目的 研究胸水细胞端粒酶活性对良恶性胸水的鉴别价值。方法 采用TRAP -Hyb法直接检测并在去除胸水淋细胞后再检测胸水细胞端粒酶活性 ,将检测结果和临床诊断进行比较。结果 直接检测胸水细胞端粒酶活性显示 5 4例良性胸水有 4例阳性、3 3例恶性胸水有 2 6例阳性 (P <0 .0 1) ,去除胸水淋巴细胞后胸水细胞端粒酶活性显示良性组有 1例阳性、恶性组有 2 3例阳性 (P <0 .0 1)。去除胸水淋巴细胞前后胸水细胞端粒酶活性诊断效能分别如下 :诊断灵敏度 0 .788和 0 .697、特异度为 0 .92 6和 0 .982、阳性预示值 0 .867和 0 .95 8、阳性似然比 10 .63 6和 3 7.63 6。结论 胸水细胞端粒酶活性的检测有助于鉴别良恶性胸水 。 Objective To study the diagnostic value of telomerase activity in differentiating malignant from bengin pleural effusions.Methods Eighty-seven specimens of pleural effusion cells were examined for telo merase activity by TRAP(telo serase repeat amplification protocol)-Hyb(hybrid) method. The results of telomerase activity examined before and after doing away those lymphocytes separated from which were compared with the final clinical diagnosises.Results Telomerase activity was detected directlt in 4 of 54 specimens of bengin pleural effusion cells and 26 of 33 samples of malignant pleural effusion cells( P <0.01). Simultaneously, 1 of 54 specimens of bengin pleural effusion cells were found to possess telomerase activity and 23 of 33 samples of malignant pleural effusion cells showed positive enzymatic activity after doing away those lymphocytes( P <]0.01). The diagnostic efficiency of telomerase activity is respectively as following:sensitivity 0.788 and 0.697,specificity 0.926 and 0.982,positive predictive value0.01). The diagnostic efficiency of telomerase activity is respectively as following:sensitivity 0.788 and 0.697,specificity 0.926 and 0.982,positive predictive value 0.867 and 0.958,positive likelihood ratio 10.636 and 37.636.Conolusion The results indicate that the detection of telomerase activity in pleural effusions is beneficial to differentiate malignant from bengin pleural effusions, and the diagnostic efficiency of telomerase activity examined after doing away those lymphocytes is superior to which including lymphocytes.
出处 《安徽医学》 2002年第6期19-21,共3页 Anhui Medical Journal
基金 铜陵市科技委员会 1 999年立项课题
关键词 良性胸腔积液 恶性胸腔积液 端粒酶 淋巴细胞 鉴别诊断 Pleural effusion Telomerase Lymphocyte Diagnosis
  • 相关文献

参考文献6

二级参考文献12

  • 1[1]Kim NW, Piatyszed MA, Prowse KB, et al. Specific association of human telomerase with immortal cells and cancer [J]. Science, 1994,266:2011-2015.
  • 2[2]Savoysky E, Akamatsu K, Tsuchiya M, et al. Detection of telomerase activity by combination of TRAP method and scintillation proximity assay (SPA) [J]. Nucleic Acids Res, 1996, 24:1175-1176.
  • 3[3]Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers [J]. J Natl Cancer Inst, 1995, 87:895-902.
  • 4[4]Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer [J]. Cancer Res, 1995, 55(150):3258-3262.
  • 5[5]Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors [J]. J Natl Cancer Inst, 1996, 88:116-122.
  • 6[6]Kishimoto Y, Murakami Y, Shiraishi, et al. Aberration of the p53 tumor suppressor gene in human non-small cell carcinoma of the lung [J]. Cancer Res, 1992, 52:4799-4804.
  • 7[7]Quinlan DC, Davidson AG, Summers CL, et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer [J]. Cancer Res, 1992, 52:4828-4831.
  • 8[8]Brambilla E, Gazzeri S, Moro D, et al. Immunohistochemical study of p53 in human lung carcinomas [J]. AM J Pathol, 1993, 143:199-210.
  • 9[9]Lamdberg G, Nielsen NH, Nilsson P, et al. Telomerase activity in associated with cell cycle deregulation in human breast cancer[J]. Cancer Res, 1997, 57:549-554.
  • 10吴珊,刘宗石,孙宏明,钟尚志,李晓明,幸凌,宇丘,殷庆,吴秉铨,李川军.人乳腺浸润性导管癌端粒酶活性的检测[J].中华医学杂志,1998,78(7):515-516. 被引量:9

共引文献21

同被引文献19

  • 1朱慕云,李昌喜,姜正华,丁平,王晓玲.联合测定胸水端粒酶和神经元特异性烯醇化酶对良恶性胸水的鉴别诊断价值[J].临床荟萃,2004,19(23):1336-1337. 被引量:2
  • 2魏仲航,杨杰,魏延君.端粒酶和CYFRA 21-1测定对良恶性胸腔积液的诊断价值[J].中国实验诊断学,2006,10(6):583-585. 被引量:2
  • 3BENNETTR,MASKELL N.Management of malignant pleural effusions[J].Current Opinion in Pulmonary Medicine,2005,11(4):296-300.
  • 4DIKMEN G,DIKMEN E,KAM M,et al.Diagnostic implications of telomemse activity in pleural effusions[J].Eur Respir,2003,22:422-426.
  • 5ZAMORA J,ABRAIRA V,MURIELA,et al.Meta-Disc:A software for meta-analysis of test accuracy data[J].BMC Med Res Methodoi,2006,6:31.
  • 6YANG C T,LEE M H,LAN R S,et al.Telomerase activity in pleural effusions:diagnostic significance[J].Clin Oncol,1998,16(2):567-573.
  • 7BRAUNCHWEIG R,YAN P,GUILLERET I,et al.Detection of malignant effusions:comparison of a telomerase assay and cytologic examination[J].Diagn Cytopathol,2001,24(3):174-180.
  • 8DIKMEN G,DIKMEN E,KARA M,et al.Diagnostic ireplications of telomerase activity in pleural effusions[J].Eur Respir,2003,22(3):422-426.
  • 9LEE W Y.Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay:comparison with cytological examination[J].Cytopathology,2005,16(5):227-232.
  • 10MANEECHOTESUWAN K,LERTWORAWIWAT A,TSCHEIKUNA J,et al.Comparison of telomerase activity between malignant and tuberculous pleural effusions[J].Med AssocThai,2006,89(5):46-54.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部